Clinical Trials Browser

INDUSTRY × FANG vaccine × Dermatologic × Clear all

NCT02574533 2017-09-27

Pilot Study of Vigil™ + Pembrolizumab for Advanced Melanoma

Phase 1 Completed

Melanoma

NCT00003715 2015-12-03

Vaccine Therapy Compared With Interferon Alfa in Treating Patients With Stage III Melanoma

Phase 2 Terminated

Melanoma